The Latest Breaking News from JJ.

Scientists have offered a new explanation for why COVID-19 vaccines that contained adenoviruses carried a rare-but-serious risk of blood clotting.

The exit of a Johnson & Johnson exec raises an age-old question about women's ambition.

Joe Wolk, with J&J for over 25 years, talks about his path and the company's focus on innovation.

In a series of moves experts say signal a shift in how developing countries deal with pharmaceuticals, South Africa, Colombia and others have recently adopted a more combative approach towards drugmakers, pushing back on policies that deny treatment to millions of people with tuberculosis and HIV